Ambuja Cements said it has participated in the e-auction tender of limestone block for Nandgaon Ekodi Limestone block in Chandrapur district of Maharashtra by the state government of Maharashtra. The company has secured an estimated limestone of 42 million tones at a final bid price of 125.05% of value of mineral dispatched. The company is expecting a formal communication vesting the said block in its favour shortly, it said. The announcement was made after market hours yesterday, 3 July 2017.
YES Bank said its board will meet on 26 July 2017 to consider stock split. The announcement was made after market hours yesterday, 3 July 2017.
Sun Pharmaceutical Industries and Samsung BioLogics announced a strategic long-term manufacturing agreement for Tildrakizumab. The agreement was entered into by Sun Pharma's wholly-owned subsidiary and Samsung BioLogics. According to the agreement, Sun Pharma has appointed Samsung BioLogics to manufacture Tildrakizumab, an investigational IL-23p19 inhibitor being evaluated for the treatment of moderate to severe plaque psoriasis. Filings for this novel investigational biologic has been accepted for review by the U.S. Food and Drug Administration (FDA) (May 2017) and the European Medicines Agency (EMA) (March 2017). The agreement was signed at Samsung BioLogics' headquarter in Incheon, South Korea. The approximate value of the contract will be $55.5 million, other financial details of the agreement are confidential. The announcement was made before trading hours today, 4 July 2017.
Wockhardt said it has received final approval from the United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for 0.1% ophthalmic solution of Olopatadine HCI. The eye drop Olopatadine HCI 0.1% ophthalmic solution is a generic version of Patanol, marketed in the United States by Alcon, a subsidiary of Novartis.
The product will be manufactured at a USFDA approved contract manufacturing organization, based in Montreal, Canada. The announcement was made after market hours yesterday, 3 July 2017.
JSW Steel said it has received shareholders' approval to raise over Rs 14,000 crore through various securities. The announcement was made after market hours yesterday, 3 July 2017.
Shareholders during the company's annual general meeting gave consent for private placement of redeemable non- convertible debentures aggregating up to Rs 10000 crore. Besides, an approval was also given for issuance of non-convertible debentures with warrants for an amount not exceeding Rs 4000 crore and/or issue of equity shares or fully, partly or optionally convertible debentures or any other convertible securities (other than warrants).
More From This Section
Jindal Poly Films said it will acquire Netherlands-based Apeldoorn Flexible Packaging Holding BV through its subsidiary in an all-cash deal, marking its foray into the load security films market. The announcement was made after market hours yesterday, 3 July 2017.
Powered by Capital Market - Live News